← Leaderboards
Stephen L. Eck
University Of Pennsylvania
$1,099,571
Attributed
$1,099,571
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,099,571 · 3
By mechanism
P01$610,855 · 1
M01$248,292 · 1
R01$240,424 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Daniel Sterman$5,215,085
- Meenhard Herlyn$50,214,821
- Wafik S El-Deiry$15,004,115
- Steven Mark Albelda$22,046,338
- Alan R Davis$1,962,961
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyGliomaHuman Therapy EvaluationHuman SubjectClinical Trial Phase INeoplasm /Cancer ImmunotherapyInterferon BetaClinical ResearchAdenoviridaeTumor AntigensLaboratory MouseVaccine DevelopmentCell TypeColon NeoplasmsDosageInterleukin 2Neoplasm /Cancer TherapyNeoplasm /Cancer VaccineActive ImmunizationDendritic CellsLeukocyte Activation /TransformationMhc Class Ii AntigenNeoplasm /Cancer ImmunologyCathepsin D
Grant awards (10)
MECHANISMS OF ADENOVIRUS VACCINES FOR COLON CANCER$228,401
P01 · FY2002 · CA
TREATMENT OF RECURRENT/PROGRESSIVE MALIGNANT GLIOMA WITH H5 010CMVHINF ADENOVIRUS$124,146
M01 · FY2002 · RR
INHIBITION OF T CELLS BY A TUMOR ASSOCIATED PROTEIN$240,424
R01 · FY2001 · CA
MECHANISMS OF ADENOVIRUS VACCINES FOR COLON CANCER$228,401
P01 · FY2001 · CA
TREATMENT OF RECURRENT/PROGRESSIVE MALIGNANT GLIOMA WITH H5 010CMVHINF ADENOVIRUS$124,146
M01 · FY2001 · RR
TREATMENT OF RECURRENT/PROGRESSIVE MALIGNANT GLIOMA WITH H5 010CMVHINF ADENOVIRUS$0
M01 · FY2001 · RR
MECHANISMS OF ADENOVIRUS VACCINES FOR COLON CANCER$154,053
P01 · FY2000 · CA
TREATMENT OF RECURRENT/PROGRESSIVE MALIGNANT GLIOMA WITH H5 010CMVHINF ADENOVIRUS$0
M01 · FY2000 · RR
TREATMENT OF RECURRENT/PROGRESSIVE MALIGNANT GLIOMA WITH H5 010CMVHINF ADENOVIRUS$0
M01 · FY2000 · RR
TREATMENT OF RECURRENT/PROGRESSIVE MALIGNANT GLIOMA WITH H5 010CMVHINF ADENOVIRUS$0
M01 · FY2000 · RR